Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3051

Actual shortage: 226 (7%)
Anticipated shortage: 17 (1%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2017-10-11 2018-03-13 25304
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-27 2018-04-17 30805
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-12-20 2018-03-21 33867
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-ISMN 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-05-22 2018-08-09 50044
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55264
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55267
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2018-08-01 55299

Showing 81 to 100 of 3051

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-07-22 71439
IBUPROFEN CAPLETS 400MG TABLET Discontinued 2019-01-07 2019-07-13 71451
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-07-12 2019-07-13 89135
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIPYRIDAMOLE 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DIPYRIDAMOLE 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574

Showing 221 to 240 of 356